Keith Johns Email

Chief Operating Officer (CSO) . Adipo Therapeutics

Current Roles

Employees:
10
Revenue:
$1.6M
About
Adipo Therapeutics, an Indiana biotechnology company, is developing polymer-based, Notch-inhibiting nanoparticles that are injected directly into adipose (fat) tissue to induce browning, or white-to-beige adipocyte transformation. The goal? Reducing weight and restoring metabolic balance for millions of people living with diabetes.
Adipo Therapeutics Address

null, null
United States
Adipo Therapeutics Email